Examine the data and tweets to deduce if the closing price of $amgn will boost or lower at 2017-09-13. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-08-29,-0.9,0.1,-1.1,0.3,0.3,-1.0,-1.4,-1.4,-1.0,-0.7,0.1
2017-08-30,-0.8,0.8,-1.2,0.8,0.8,-1.3,-2.1,-2.2,-1.8,-1.5,-0.8
2017-08-31,-2.3,0.5,-2.3,2.4,2.4,-2.7,-3.8,-4.1,-3.9,-3.6,-3.1
2017-09-01,-0.3,0.6,-0.8,0.5,0.5,-2.2,-3.7,-4.2,-4.2,-4.0,-3.6
2017-09-05,0.7,1.0,-0.8,-1.1,-1.1,-0.5,-2.1,-2.9,-3.1,-2.9,-2.6
2017-09-06,-0.4,0.4,-1.1,0.9,0.9,-0.7,-2.6,-3.5,-3.8,-3.6,-3.5
2017-09-07,-1.2,1.1,-1.9,1.3,1.3,-1.2,-3.2,-4.4,-4.8,-4.7,-4.7
2017-09-08,0.2,1.1,-0.6,-0.0,-0.0,-0.9,-2.5,-3.9,-4.4,-4.5,-4.5
2017-09-11,-2.1,0.1,-2.1,3.2,3.2,-3.2,-4.7,-6.2,-6.9,-7.2,-7.2
2017-09-12,-2.1,0.0,-2.2,2.4,2.4,-4.0,-6.0,-7.6,-8.6,-9.0,-9.1

2017-08-29: $amgn open interest for maturity 09/01/2017. high put=170.00 high call=172.50 #maxpain #options¡­ |celgene $celg ebitda multiple of 24.8x doesn't look attractive vs peers: $bmy $abbv $mrk $shpg $amgn¡
2017-08-30: interview with connor bruggeman schooltrader extraordinaire!:  $nflx $himx $ino $amgn $googl|btw, estimated #earnings per share for $amgn is $3.09 it's 1.79% of the current price |$amgn amgen option o
2017-08-31: how about $arwr and $amgn as the next california hook-up? |picked up 20 lotto $blue $135 sept 15 calls $2.10 many rumours of $celg buying them over the long weekend &amp; rumors $amgn also interested|
2017-09-01: ask slim market week friday, september 1 $au $bby $dg $x $aapl $amgn $cien $gld $spx |ask slim market week friday, september 1 $au $bby $dg $x $aapl $amgn $cien $gld $spx |s&amp;p100 #stocks performan
2017-09-02: berkshire asset management increased amgen $amgn stake by $4.87 million as market valuation declined ...|best long-term bets in biotech/healthcare    $amgn $regn $unh |best long-term bets in biotech/h
2017-09-03: $aapl $amat $amgn $amtd $amzn $atvi trade long and short positions from the #nasdaq, up to 1500% since 2010.  $spy| this student made $50k trading jason bond alerts! full review! $pfe $expe $amgn $bbr
2017-09-04: $amgn ripped though it's gap, hard to start a position here |rt AT_USER noxxon pharma, $lly &amp; $amgn were developing functional hepcidin antagonists for anemia. they¡¯ve abandoned their programs. $
2017-09-05: rt AT_USER #venturecapital if you appreciate investment in noble cause for good of mankind $nwbo has potential of $aapl .40c 1986¡­|longer consolidation bigger move can be $amgn |if you followed me in
2017-09-06: $amgn tezepelumab significantly reduced asthma exacerbations f¡­ |$amgn: amgen and astrazeneca (azn) results from the pathway phase 2b trial of tezepelumab that showed a... |commented on  $adms $alny 
2017-09-07: $amgn news. see what flies tomorrow...|rt AT_USER $amgn new data demonstrate aimovig erenumab reduced monthly migraine days in patients who failed previous therapies |$chrs $amgn coherus biosciences i
2017-09-08: rt AT_USER video  stock mkt video analysis 9/8/17 $spy $gnrc $qqq $nflx $iwm $ibb $amgn |rt AT_USER health care and biotech stocks are on a tear this year, and carter and AT_USER think $amgn has even 
2017-09-09: $amgn - breakout watch #182.8, target - 184, 191. stop: 178. short potential targets - 177, 169, 164. cover: 183|rt AT_USER video  stock mkt video analysis 9/8/17 $spy $gnrc $qqq $nflx $iwm $ibb $amgn
2017-09-10: rt AT_USER my video   stock mkt video analysis 9/8/17 $spy $gnrc $qqq $nflx $iwm $ibb $amgn |rt AT_USER my video   stock mkt video analysis 9/8/17 $spy $gnrc $qqq $nflx $iwm $ibb $amgn |rt AT_USER my 
2017-09-11: big call buyers  $bhp $teva $splk $mgm $oi $mac $intc $arry $wfc $snap $bidu $efx $cbs $qcom $amgn $nke $idti $ko|rt AT_USER mon-wed: morgan stanley 150 healthcare webcasts $abbv $agn $alxn $amgn $bii
2017-09-12: clean breakout for $amgn on the monthly chart. looks like it wants $200. measured move targets $220. |rt AT_USER $amgn looks pretty serious this time |big call buyers  $bac $amtd $mu $ttm $twtr $wsm $
Answer:
Examine the data and tweets to deduce if the closing price of $amgn will boost or lower at 2017-09-13. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-08-29,-0.9,0.1,-1.1,0.3,0.3,-1.0,-1.4,-1.4,-1.0,-0.7,0.1
2017-08-30,-0.8,0.8,-1.2,0.8,0.8,-1.3,-2.1,-2.2,-1.8,-1.5,-0.8
2017-08-31,-2.3,0.5,-2.3,2.4,2.4,-2.7,-3.8,-4.1,-3.9,-3.6,-3.1
2017-09-01,-0.3,0.6,-0.8,0.5,0.5,-2.2,-3.7,-4.2,-4.2,-4.0,-3.6
2017-09-05,0.7,1.0,-0.8,-1.1,-1.1,-0.5,-2.1,-2.9,-3.1,-2.9,-2.6
2017-09-06,-0.4,0.4,-1.1,0.9,0.9,-0.7,-2.6,-3.5,-3.8,-3.6,-3.5
2017-09-07,-1.2,1.1,-1.9,1.3,1.3,-1.2,-3.2,-4.4,-4.8,-4.7,-4.7
2017-09-08,0.2,1.1,-0.6,-0.0,-0.0,-0.9,-2.5,-3.9,-4.4,-4.5,-4.5
2017-09-11,-2.1,0.1,-2.1,3.2,3.2,-3.2,-4.7,-6.2,-6.9,-7.2,-7.2
2017-09-12,-2.1,0.0,-2.2,2.4,2.4,-4.0,-6.0,-7.6,-8.6,-9.0,-9.1

2017-08-29: $amgn open interest for maturity 09/01/2017. high put=170.00 high call=172.50 #maxpain #options¡­ |celgene $celg ebitda multiple of 24.8x doesn't look attractive vs peers: $bmy $abbv $mrk $shpg $amgn¡
2017-08-30: interview with connor bruggeman schooltrader extraordinaire!:  $nflx $himx $ino $amgn $googl|btw, estimated #earnings per share for $amgn is $3.09 it's 1.79% of the current price |$amgn amgen option o
2017-08-31: how about $arwr and $amgn as the next california hook-up? |picked up 20 lotto $blue $135 sept 15 calls $2.10 many rumours of $celg buying them over the long weekend &amp; rumors $amgn also interested|
2017-09-01: ask slim market week friday, september 1 $au $bby $dg $x $aapl $amgn $cien $gld $spx |ask slim market week friday, september 1 $au $bby $dg $x $aapl $amgn $cien $gld $spx |s&amp;p100 #stocks performan
2017-09-02: berkshire asset management increased amgen $amgn stake by $4.87 million as market valuation declined ...|best long-term bets in biotech/healthcare    $amgn $regn $unh |best long-term bets in biotech/h
2017-09-03: $aapl $amat $amgn $amtd $amzn $atvi trade long and short positions from the #nasdaq, up to 1500% since 2010.  $spy| this student made $50k trading jason bond alerts! full review! $pfe $expe $amgn $bbr
2017-09-04: $amgn ripped though it's gap, hard to start a position here |rt AT_USER noxxon pharma, $lly &amp; $amgn were developing functional hepcidin antagonists for anemia. they¡¯ve abandoned their programs. $
2017-09-05: rt AT_USER #venturecapital if you appreciate investment in noble cause for good of mankind $nwbo has potential of $aapl .40c 1986¡­|longer consolidation bigger move can be $amgn |if you followed me in
2017-09-06: $amgn tezepelumab significantly reduced asthma exacerbations f¡­ |$amgn: amgen and astrazeneca (azn) results from the pathway phase 2b trial of tezepelumab that showed a... |commented on  $adms $alny 
2017-09-07: $amgn news. see what flies tomorrow...|rt AT_USER $amgn new data demonstrate aimovig erenumab reduced monthly migraine days in patients who failed previous therapies |$chrs $amgn coherus biosciences i
2017-09-08: rt AT_USER video  stock mkt video analysis 9/8/17 $spy $gnrc $qqq $nflx $iwm $ibb $amgn |rt AT_USER health care and biotech stocks are on a tear this year, and carter and AT_USER think $amgn has even 
2017-09-09: $amgn - breakout watch #182.8, target - 184, 191. stop: 178. short potential targets - 177, 169, 164. cover: 183|rt AT_USER video  stock mkt video analysis 9/8/17 $spy $gnrc $qqq $nflx $iwm $ibb $amgn
2017-09-10: rt AT_USER my video   stock mkt video analysis 9/8/17 $spy $gnrc $qqq $nflx $iwm $ibb $amgn |rt AT_USER my video   stock mkt video analysis 9/8/17 $spy $gnrc $qqq $nflx $iwm $ibb $amgn |rt AT_USER my 
2017-09-11: big call buyers  $bhp $teva $splk $mgm $oi $mac $intc $arry $wfc $snap $bidu $efx $cbs $qcom $amgn $nke $idti $ko|rt AT_USER mon-wed: morgan stanley 150 healthcare webcasts $abbv $agn $alxn $amgn $bii
2017-09-12: clean breakout for $amgn on the monthly chart. looks like it wants $200. measured move targets $220. |rt AT_USER $amgn looks pretty serious this time |big call buyers  $bac $amtd $mu $ttm $twtr $wsm $
Answer:+Fall